News
CuraTeQ Biologics s.r.o., announced that the CHMP of the European Medicines Agency has adopted a positive opinion recommending marketing authorisation of Dazublys®, its trastuzumab biosimilar, for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback